Jinlong Tang

1.6k total citations
47 papers, 1.2k citations indexed

About

Jinlong Tang is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Jinlong Tang has authored 47 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Surgery and 10 papers in Cancer Research. Recurrent topics in Jinlong Tang's work include Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (6 papers) and Cervical Cancer and HPV Research (5 papers). Jinlong Tang is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (6 papers) and Cervical Cancer and HPV Research (5 papers). Jinlong Tang collaborates with scholars based in China, United States and Hong Kong. Jinlong Tang's co-authors include Honghe Zhang, Jingyu Wang, Maode Lai, Enping Xu, Jianlu Kong, Yihua Wu, Hongfei Yu, Qi Zhang, Qihan Fu and Yiwen Chen and has published in prestigious journals such as PLoS ONE, Analytical Chemistry and Hepatology.

In The Last Decade

Jinlong Tang

39 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinlong Tang China 17 699 572 194 191 175 47 1.2k
Sergio Caja Finland 12 617 0.9× 386 0.7× 161 0.8× 96 0.5× 128 0.7× 16 1.1k
Yinying Dong China 17 524 0.7× 347 0.6× 164 0.8× 334 1.7× 116 0.7× 30 1.2k
Juan Bayo Argentina 23 586 0.8× 207 0.4× 155 0.8× 212 1.1× 122 0.7× 42 1.1k
Alice Banh United States 12 661 0.9× 441 0.8× 162 0.8× 170 0.9× 102 0.6× 14 1.1k
Anastasia Chillà Italy 23 667 1.0× 336 0.6× 234 1.2× 265 1.4× 56 0.3× 45 1.1k
Kate Vandyke Australia 22 709 1.0× 188 0.3× 167 0.9× 411 2.2× 60 0.3× 47 1.3k
Zongliu Hou China 19 445 0.6× 194 0.3× 184 0.9× 284 1.5× 114 0.7× 59 993
Qingcheng Yang China 22 658 0.9× 411 0.7× 93 0.5× 196 1.0× 72 0.4× 55 1.0k
Ying Ma China 20 741 1.1× 310 0.5× 480 2.5× 620 3.2× 100 0.6× 81 1.7k
Xiaolin Lin China 20 599 0.9× 368 0.6× 145 0.7× 147 0.8× 72 0.4× 45 1000

Countries citing papers authored by Jinlong Tang

Since Specialization
Citations

This map shows the geographic impact of Jinlong Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinlong Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinlong Tang more than expected).

Fields of papers citing papers by Jinlong Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinlong Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinlong Tang. The network helps show where Jinlong Tang may publish in the future.

Co-authorship network of co-authors of Jinlong Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Jinlong Tang. A scholar is included among the top collaborators of Jinlong Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinlong Tang. Jinlong Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Tang, Jinlong, et al.. (2024). GPR137 inactivates Hippo signaling to promote gastric cancer cell malignancy. Biology Direct. 19(1). 3–3. 5 indexed citations
3.
Qian, Lili, et al.. (2024). Cytoplasmic expression of UTP23 promotes colorectal cancer progression. Cellular and Molecular Biology. 70(1). 239–245. 1 indexed citations
4.
Li, Chang, Yi Li, Qian Shang, et al.. (2023). In vivo differentiation of adenoma and carcinoma in CRC progression by PAR2-M/DiD ratiometric fluorescence and its microstructures. Sensors and Actuators B Chemical. 394. 134482–134482. 1 indexed citations
5.
Du, Hui, Wenkui Dai, Qian Zhou, et al.. (2023). AI-assisted system improves the work efficiency of cytologists via excluding cytology-negative slides and accelerating the slide interpretation. Frontiers in Oncology. 13. 1290112–1290112. 5 indexed citations
6.
Li, Yuan, et al.. (2023). Epithelioid and spindle rhabdomyosarcoma with TFCP2 rearrangement in abdominal wall: a distinctive entity with poor prognosis. Diagnostic Pathology. 18(1). 41–41. 3 indexed citations
7.
Lai, Chong, Jinlong Tang, Qin Liu, et al.. (2023). SCGN and STAT3 expressions are associated with the prognosis of ccRCC. Pathology - Research and Practice. 252. 154940–154940. 3 indexed citations
8.
Sun, Zhongquan, Jinlong Tang, Binglin Ye, et al.. (2023). Adjuvant therapy for cholangiocarcinoma after surgery and prognosis factors for cholangiocarcinoma: A single-center retrospective cohort study. Frontiers in Oncology. 13. 1116338–1116338. 4 indexed citations
9.
Yu, Hongfei, Chaoyi Chen, Fengyan Han, et al.. (2022). Long Noncoding RNA MIR4435-2HG Suppresses Colorectal Cancer Initiation and Progression By Reprogramming Neutrophils. Cancer Immunology Research. 10(9). 1095–1110. 27 indexed citations
10.
Tang, Jinlong, Yuan Li, Shuli Xia, et al.. (2021). Sequestosome 1/p62: A multitasker in the regulation of malignant tumor aggression (Review). International Journal of Oncology. 59(4). 39 indexed citations
11.
Ding, Yuan, et al.. (2021). Systemic Sequential Therapy of CisGem, Tislelizumab, and Lenvatinib for Advanced Intrahepatic Cholangiocarcinoma Conversion Therapy. Frontiers in Oncology. 11. 691380–691380. 10 indexed citations
12.
Cheng, Qi, et al.. (2018). Total hip arthroplasty following failure of tantalum rod implantation for osteonecrosis of the femoral head with 5- to 10-year follow-up. BMC Musculoskeletal Disorders. 19(1). 289–289. 18 indexed citations
13.
Liu, Chong, Hui Du, Chun Wang, et al.. (2017). HPV L1 and P16 Expression in CIN1 to Predict Future CIN2+. International Journal of Gynecological Pathology. 36(3). 281–288. 5 indexed citations
14.
Tang, Jinlong, et al.. (2016). Primary intracerebral osteosarcoma: a rare case report and review. SpringerPlus. 5(1). 1997–1997.
15.
Li, Qinghai, Ziyu Liu, Jinlong Tang, et al.. (2016). Inflammatory pseudotumor of the pineal region: First reported case. Oncology Letters. 11(3). 2127–2130.
16.
Chen, Qing, Hui Du, Chun Wang, et al.. (2016). p16 Immunohistochemistry in Colposcope-Directed and Random Cervical Biopsies of CIN2 and CIN3. Journal of Lower Genital Tract Disease. 20(3). 197–200. 5 indexed citations
17.
Wang, Jingyu, et al.. (2016). Molecular mechanisms and clinical applications of miR-22 in regulating malignant progression in human cancer (Review). International Journal of Oncology. 50(2). 345–355. 81 indexed citations
18.
Luo, Hongxue, Hui Du, Kathryn A. Maurer, et al.. (2016). An Evaluation of the Cobas4800 HPV Test on Cervico-Vaginal Specimens in Liquid versus Solid Transport Media. PLoS ONE. 11(2). e0148168–e0148168. 8 indexed citations
19.
Wang, Jingyu, Jinlong Tang, Maode Lai, & Honghe Zhang. (2014). 5-Hydroxymethylcytosine and disease. Mutation Research/Reviews in Mutation Research. 762. 167–175. 43 indexed citations
20.
Zhang, Honghe, Jinlong Tang, Chen Li, et al.. (2014). MiR-22 regulates 5-FU sensitivity by inhibiting autophagy and promoting apoptosis in colorectal cancer cells. Cancer Letters. 356(2). 781–790. 139 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026